News Gedeon Richter

Stocks

RICHTER

HU0000123096

Pharmaceuticals

Delayed Budapest S.E. 19:20:00 02/11/2026 +03			5-day change	1st Jan Change
13,000.00 ^HUF	+0.39%		-3.27%	+31.78%

10-14	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI
09-18	EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug	MT

All News

Mentions Relevance

10-14	Gedeon Richter : Richter receives FDA Submission Acceptance of New Drug Application for FYLREVY in the U.S.	PU
10-14	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI
08-11	Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026
08-07	Gedeon Richter PLC Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-07	Gedeon Richter : Richter publishes Q2/H1 2026 results	PU
08-06	Gedeon Richter : Richter and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care	PU
08-06	Gedeon Richter plc and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care	CI
06-29	Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026	CI
06-10	Gedeon Richter : Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)	PU
06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI
05-29	Gedeon Richter PLC Approves Dividend for the Financial Year 2025	CI
05-27	Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia	RE
05-27	Gedeon Richter : Richter and Acrux agree to license Lenzetto® for Australia	PU
05-16	Gedeon Richter PLC, Q1 2026 Earnings Call, May 12, 2026
05-14	Gedeon Richter : Transactions with Treasury Shares	PU
05-12	Gedeon Richter PLC Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-12	Gedeon Richter : Extraordinary Information	PU
05-12	Hungary's Richter says 2026 guidance fully reiterated high-single-digit growth in revenues and clean EBIT (at constant exchange rates)	RE
05-12	Gedeon Richter : Interim management statement	PU
05-12	Gedeon Richter : RichterIRpresentation May 2026	PU
05-12	Gedeon Richter : PresentationQ12026	PU
05-12	Gedeon Richter : Richter publishes Q1 2026 results	PU
05-12	Gedeon Richter : Earnings presentation Q1 2026 (PresentationQ12026)	PU
05-12	Gedeon Richter : Investor presentation Q1 2026 (RichterIRpresentation May 2026)	PU
05-12	Gedeon Richter Seeks Acquisitions	CI